The December issue of EuroIntervention is out now featuring: ➡️State-of-the-art on - NSTE-ACS management - Calcified nodules in PCI ➡️New evidence on β-blockers post-MI ➡️Abbreviated antiplatelet therapy in HBR patients with CKD ➡️Thrombosis after Reducer

This new Consensus provided a comprehensive framework for managing patients with transvalvular CIED leads undergoing transcatheter #tricuspid interventions. It clarified mechanisms of lead–valve interaction, outlined risks and implications of lead jailing, and defined when lead

🚨 THIS IS YOUR LAST CHANCE We’ve reached the final day of CyberStacks. But before the show is over, you can still get a slice of the total $30,000 in cash drops! If you’re playing today, drop your favourite emoji in the comments. Let’s finish CyberStacks with a full table!

🎧 New Turning Point podcast! This week, Lars Søndergaard reflects on a career shaped by unexpected opportunities — from structural interventions & first-in-human procedures to major trials like NOTION and key work on PFO. He also shares pragmatic advice for young cardiologists:

The CANNULATE TAVR EXPANDED study reported high feasibility of coronary cannulation after TAVI with the Evolut FX. Post-TAVI CT showed high rates of commissural and coronary alignment, while misalignment was the strongest predictor of delayed or suboptimal cannulation. #TAVI

This Viewpoint by Won-Keun Kim and Helge Möllmann reviewed the factors surrounding the discontinuation of the ACURATE transcatheter valve platform, contextualising recent trial data and real-world insights to inform ongoing discussions in TAVI practice. #TAVI

1/15 He is a director who defies genre and culture, creating films that are as emotionally intimate as they are technically brilliant. He’s won the Best Director Oscar twice for two completely different films. This is the story of the cinematic master, Ang Lee.

Early results from the TRICURE FIH study show that the Topaz TTVR system achieved complete TR elimination, with all patients reaching none/mild TR at 30 days and 100% device success. A step forward for TTVR in high-risk TR patients. @PatrizioLancel2 @LeopoldOliver86

New data from the OCEAN-TAVI registry: among 2,699 pts treated with SAPIEN 3, long-term outcomes and BE-THV durability were comparable between small and large aortic annuli. BVF remained infrequent (3.2% at 7 yrs), and annular size showed no association with mortality or BVF.

Happening at PCR London valves 2025: 🔎Zoom on the most impactful papers on valvular heart disease published this year in EuroIntervention #PCRLV

📢 Prepare to welcome a new member of the EuroIntervention Journal Family - a new peer-reviewed journal is on its way.! We're delighted to announce that in 2026 we will be launching EuroIntervention Case Reports - the first and only case report journal dedicated to

New data from the OCEAN-TAVI CT substudy: hypoattenuating leaflet thickening (HALT) occurred in 21.3% of patients after SAPIEN 3 Ultra RESILIA TAVI. HALT was strongly linked to THV deformation and asymmetric leaflet expansion, while the revised leaflet suspension design showed no

Another Simultaneous Publication #PCRLV today! Early clinical results of the DurAVR balloon-expandable THV in small aortic annuli show excellent 30-day performance: 🔹 93% technical success 🔹 Mean gradient 8.2 mmHg 🔹 EOAi 2.2 cm² 🔹 Moderate PPM only 3% Promising early

Simultaneously published with #PCRLV : @GilbertTangMD et al. present 5-year outcomes of the early-generation Intrepid transapical TMVR system, demonstrating sustained MR elimination, stable hemodynamics and consistent clinical improvement. https://t.co/ydCBnsR4Jc @psorajja ;

Bicuspid is no longer a niche. In this new SOTA, @didier_tchetche et al walk through TAVI in BAV: phenotypes, CT sizing (BAVARD, circle, CASPER), procedural tricks, long-term concerns and the need for TAVI vs SAVR RCTs. #TAVI #cardiotwitter #CardioX #CardioEd #PCRLV

‼️New issue – PCR London Valves Edition‼️ ✅SOTA on TAVI in bicuspid AS ✅ EHRA/EAPCI expert consensus on tricuspid interventions with RV leads; ✅ Viewpoint on ACURATE’s discontinuation; ✅ new data on coronary cannulation after Evolut FX, ✅HALT with SAPIEN Ultra

The Lanzera Jackal. For wherever football takes you.

Some great practical tips as you get ready for #PCRLV 🇬🇧 Don’t forget your ETA 😉

London Valves is just around the corner, guys!! A ton of sensational education content in the pipeline🔥 Will you be onboard this year? #PCRlondonValves @PCRonline

H2H | What is the future of coronary interventions: DES, DEB and/or BRS?

From trial to real-world care In the Danish registry recently published, @JacobsenRavn et al. showed prasugrel’s advantage over ticagrelor after PCI for MI — confirming ISAR-REACT 5. @adnan_kastrati & @FiorenzoSimo discuss how real-world evidence closes the loop from RCTs to

Concertina effect or plaque rupture? OCT findings in ACS can mislead — this case highlights a wire-induced pseudostenosis mistaken for rupture, resolved by careful angiographic correlation. https://t.co/f0j1YfOL86